BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10481433)

  • 1. [Epibatidine. An old work principle rediscovered].
    Hecker T; Nieber K
    Med Monatsschr Pharm; 1999 Aug; 22(8):226-32. PubMed ID: 10481433
    [No Abstract]   [Full Text] [Related]  

  • 2. Epibatidine and its analogues as nicotinic acetylcholine receptor agonist: an update.
    Yogeeswari P; Sriram D; Ratan Bal T; Thirumurugan R
    Nat Prod Res; 2006 May; 20(5):497-505. PubMed ID: 16644549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epibatidine and pain.
    Traynor JR
    Br J Anaesth; 1998 Jul; 81(1):69-76. PubMed ID: 9771274
    [No Abstract]   [Full Text] [Related]  

  • 4. [Novel analgesics: neuronal nicotinic acetylcholine receptor agonists].
    Li LJ; Liu CG
    Sheng Li Ke Xue Jin Zhan; 2001 Oct; 32(4):324-7. PubMed ID: 12545860
    [No Abstract]   [Full Text] [Related]  

  • 5. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
    Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice.
    Damaj MI; Martin BR
    Eur J Pharmacol; 1996 Apr; 300(1-2):51-7. PubMed ID: 8741164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
    Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
    Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (+/-) Epibatidine increases acetylcholine release partly through an action on muscarinic receptors.
    Kommalage M; Höglund AU
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):238-44. PubMed ID: 15125694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the research on nicotinic acetylcholine receptors agonists].
    Chen JH; Bai DL
    Yao Xue Xue Bao; 2002 Apr; 37(4):309-15. PubMed ID: 12579830
    [No Abstract]   [Full Text] [Related]  

  • 11. New nonopioid painkiller shows promise in animal tests.
    Strauss E
    Science; 1998 Jan; 279(5347):32-3. PubMed ID: 9441405
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epibatidine structure-activity relationships.
    Carroll FI
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and binding studies of some epibatidine analogues.
    Rádl S; Hezký P; Hafner W; Budesínský M; Hejnová L
    Bioorg Med Chem Lett; 2000 Jan; 10(1):55-8. PubMed ID: 10636243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of [(3)H]epibatidine binding to nicotinic receptors from bovine adrenal medulla.
    McKay DB; Free RB; Kaser DJ; McKay SB
    Ann N Y Acad Sci; 2002 Oct; 971():162-4. PubMed ID: 12438112
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epibatidine, a nicotinic acetylcholine receptor agonist, inhibits the capsaicin response in dorsal root ganglion neurons.
    Zhang XF; McKenna DG; Briggs CA
    Brain Res; 2001 Nov; 919(1):166-8. PubMed ID: 11689175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effects of novel epibatidine analogs through activation of α4β2 nicotinic receptors.
    Li W; Cai J; Wang BH; Huang L; Fan J; Wang Y
    Sci China Life Sci; 2018 Jun; 61(6):688-695. PubMed ID: 29435707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits.
    Marubio LM; del Mar Arroyo-Jimenez M; Cordero-Erausquin M; Léna C; Le Novère N; de Kerchove d'Exaerde A; Huchet M; Damaj MI; Changeux JP
    Nature; 1999 Apr; 398(6730):805-10. PubMed ID: 10235262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.